This report (about half way down the page) back in January, referred to the Wrexham plant producing 150,000 phials a day. At six doses per phial that's 900,000 jabs. The figures I have seen don't get anywhere near that number being vaccinated everyday, even with (say) 10% wastage. The peak was at the end of January/early February.
Well done for finding that Business Live article:
The factories making Oxford-AstraZeneca, Pfizer-BioNTech and other Covid-19 vaccine in the UK
Oxford-AZ CP Pharma's Wrexham plant now has the capacity to produce (finish) about 800,000 doses a day and these are all the Oxford-AZ variety. The vaccine is actually made in England in Oxford and Keele (there's also a factory in the Netherlands). In February about 50% of the Wrexham production was exported, including to the EU. This percentage has dropped this month as the supply to UK has been ramped up. We will see 500,000+ doses overall per day being administered in UK from 14 Mar onwards so this will take more of the capacity, for several months. Most of the first jabs mid-March onwards will be Oxford-AZ. And increasing amounts will be needed for second jabs (from Easter onwards).
Oxford-AZ vaccine production is increasingly international.
Pfizer-BioNTech Nearly all the UK's Pfizer supply (e.g. from Germany (Marburg)/Belgium(Puurs)) will be used for second jabs from now on. As a contingency (to be exercised if the current under 18 trials fail), some Pfizer supply (not before August) might be earmarked for 16 and 17 year olds.
In UK the Croda plant outside Snaith (Yorkshire) has been producing/supplying four component excipients/lipids for the Pfizer/BioNTech vaccine - these have been
separately listed as: [maybe worth a read
@classic33 ?]
- ALC-0315 = (4-hydroxybutyl) azanediyl)bis (hexane-6,1-diyl)bis(2-hexyldecanoate)
- ALC-0159 = 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide
- 1,2-Distearoyl-sn-glycero-3-phosphocholine
- cholesterol
There has been no report of any UK export 'ban' being placed on the export of these vaccine 'components' which need to go to the continent for the manufacture of the final vaccine (and then fill&finish).
Moderna From now on (mid March) some people's first jab will be the Moderna mRNA vaccine - perhaps 50,000 a day average, and from early June their second jab of Moderna.
Novavax The Novavax vaccine will be
manufactured near Middleborough (Yorks), from April (Phase 3 trial successfully complete, so hopefully getting the MHRA 'OK' in April too).
Valneva The French Biotech firm's UK plant in Livingston (Scotland) will make the UK's supply of this vaccine which has yet to complete its Phase 1/2 trials (so still early days).
Janssen UK supply (idc) to be manufactured in Belgium and fill/finish at Sanofi's Marcy l'Etoile plant (France). Vaccine already being rolled out in USA and Canada.
